The South Korean manufacturer and exporter of biosimilars said it is prepared to respond regardless of how the Trump administration’s drug tariff policy might be implemented.
CDMO sales helped compensate for lower market demand for pharma capsules and softness in the company’s bioscience business, Lonza reported on Wednesday.
Evergreen’s scalable manufacturing capabilities are meant to enhance Lantheus Holdings’ ability to meet the complex demands of radiopharmaceutical development and production.
India’s contract development and manufacturing organization market is expected to grow from $7 billion to $14 billion by 2028, capturing 4% to 5% of the global CDMO market.
On average, respondents said they expect a decline in services spending this year versus 2024, according to a survey commissioned by analyst firm Leerink Partners.
Backed by Delin Ventures, the company aims to transform cancer treatment by creating therapies achieving long-term remission for patients with advanced metastatic cancers.
The cell therapy CDMO will provide technology transfer, analytical method transfer, and cGMP manufacturing to support Secretome Therapeutics’ lead asset STM-01.
The integrated CDMO is aiming to enhance manufacturing efficiencies for KaloCyte’s lead candidate, ErythroMer, a bioengineered artificial red blood cell substitute.
The companies will jointly develop and supply a portfolio of novel central nervous system-focused products using Spektus Pharma’s proprietary Flexitab technology.
The clinical hold is linked to GMP compliance issues identified during an inspection of a third-party manufacturing facility that was the basis of a Complete Response Letter.
Catalent’s cell therapy manufacturing site in Princeton, New Jersey, will facilitate production for trials in New Jersey, New York, and surrounding areas.
The combined platform will offer a fully automated and digitalized process designed to reduce CAR-T manufacturing timelines to 2.5 days, while cutting costs by over 80%.
Chris Chen on Wednesday told the J.P. Morgan Healthcare Conference in San Francisco that the Chinese-based CRDMO has become resilient amid the “clouds” of geopolitics.
The company said its CDMO business this year will be hit with lower commercial revenue, as a cell therapy client terminated their agreement with Charles River.
Under the collaboration agreement, the formulations for administration in the ICOone Nasal device will be developed at Lonza’s Center of Excellence in Bend, Oregon.
The award to ReciBioPharm, a division of Recipharm, will support the global deployment of RNA continuous manufacturing technologies to low- and middle-income countries.
The CDMO will collaborate with Pandorum on its “liquid cornea” product, while providing an exclusive GMP suite for production of Genenta’s cell therapy.
With capacity increasing from six to 12 bioreactors for mammalian cell culture, the CDMO says Hillerød is the largest end-to-end biopharma manufacturing site in Europe.
Boehringer Ingelheim has licensed Synaffix’s antibody-drug conjugate technology, while Samsung is expanding ADC services through a partnership with LigaChem Biosciences.
The San Diego-based CDMO said it made the decision to “right size” its Durham, N.C. facility “based on demand in the gene therapy sector, which requires reducing headcount.”
